Literature DB >> 12928512

Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.

Nobutsugu Hirono1, Mamoru Hashimoto, Minoru Yasuda, Hirokazu Kazui, Etsuro Mori.   

Abstract

To investigate a possible effect of the apolipoprotein (APOE) epsilon4 allele on memory decline in Alzheimer's disease (AD), we examined 64 AD patients with the APOE epsilon3/3, epsilon3/4, or epsilon4/4 allele using the Alzheimer Disease Assessment Scale-Cognitive subscale (ADAS-Cog) and its subtests at the initial examination and at the 1-year follow-up visit. One-year changes in the scores of the Word Recall subtest, Word Recognition subtest, and total ADAS-Cog were significantly correlated with the number of APOE epsilon4 alleles after controlling for the effects of age, sex, education, test interval, and baseline scores. Findings revealed that APOE epsilon4 allele is related to an accelerated memory decline in AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928512     DOI: 10.1176/jnp.15.3.354

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  12 in total

1.  When time's arrow doesn't bend: APOE-ε4 influences episodic memory before old age.

Authors:  Teal S Eich; Angeliki Tsapanou; Yaakov Stern
Journal:  Neuropsychologia       Date:  2019-08-29       Impact factor: 3.139

Review 2.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 3.  Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.

Authors:  Leo Ungar; Andre Altmann; Michael D Greicius
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

4.  APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.

Authors:  S Cosentino; N Scarmeas; E Helzner; M M Glymour; J Brandt; M Albert; D Blacker; Y Stern
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

5.  APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease.

Authors:  Yu-Ling Chang; Christine Fennema-Notestine; Dominic Holland; Linda K McEvoy; Nikki H Stricker; David P Salmon; Anders M Dale; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2013-07-27       Impact factor: 21.566

Review 6.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Endophenotypes in normal brain morphology and Alzheimer's disease: a review.

Authors:  C Reitz; R Mayeux
Journal:  Neuroscience       Date:  2009-04-09       Impact factor: 3.590

8.  The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.

Authors:  Luise Christine Löwe; Christian Gaser; Katja Franke
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

9.  The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database.

Authors:  Maowen Ba; Xiaofeng Li; Kok Pin Ng; Tharick A Pascoal; Sulantha Mathotaarachchi; Pedro Rosa-Neto; Serge Gauthier
Journal:  Alzheimers Dement (N Y)       Date:  2017-02-09

10.  Age-Related Association between Apolipoprotein E ε4 and Cognitive Function in Japanese Patients with Alzheimer's Disease.

Authors:  Tomoyuki Nagata; Shunichiro Shinagawa; Bolati Kuerban; Nobuto Shibata; Tohru Ohnuma; Heii Arai; Kazuhiko Nakayama; Hisashi Yamada
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.